Carregant...
Selegiline and the Treatment of Parkinson's Disease: How patients can benefit from drug therapy
Parkinson's disease involves the progressive degeneration of dopamine neurons in the extrapyramidal motor system. Levodopa, the metabolic precursor of dopamine, relieves symptoms but does not prevent continued cell death. Research suggests that monoamine oxidase B inhibitors, such as selegiline...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
1991
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2145357/ https://ncbi.nlm.nih.gov/pubmed/21229030 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|